R&D Q3 Clinical trials round-up: July to September 2025 As the third quarter of 2025 draws to a close, the clinical research landscape has been marked by a surge of promising data and regulatory milestones.
News COVID-19 bites into Pfizer’s Q3, but biopharma revenues rise Pfizer is one of the front-runners in the race to approve a COVID-19 vaccine
News COVID-19 ventilator demand fuels Philips Q3 sales Huge demand for ventilators and patient monitors spurred third quarter sales for Royal Philips, the company announced.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.